Adaptive Biotechnologies Q2 Loss decreases, beats estimates

August 02, 2023 — 09:47 pm EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Adaptive Biotechnologies (ADPT) reported Loss for second quarter that decreased from last year and beat the Street estimates.

The company's earnings came in at -$47.81 million, or -$0.33 per share. This compares with -$52.05 million, or -$0.37 per share, in last year's second quarter.

Analysts on average had expected the company to earn -$0.35 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 12.1% to $48.93 million from $43.66 million last year.

Adaptive Biotechnologies earnings at a glance (GAAP) :

-Earnings (Q2): -$47.81 Mln. vs. -$52.05 Mln. last year. -EPS (Q2): -$0.33 vs. -$0.37 last year. -Analyst Estimates: -$0.35 -Revenue (Q2): $48.93 Mln vs. $43.66 Mln last year.

-Guidance: Full year revenue guidance: $205 mln to $215 mln

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Adaptive Biotechnologies Q2 Loss decreases, beats estimates

Tags

Latest Articles